Diligence memo · auto-generated · as of July 2, 2026
Greenlight Biosciences Inc.
Greenlight Biosciences Inc. has raised $179M over 5 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Greenlight Biosciences Inc. operates in Biotech / Pharma, based in Medford.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Greenlight Biosciences Inc. has raised $179M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $103M on 2020-06-15.
Most recent recorded round closed around 2020-06-15.
Valuation (modeled)modeled
Provath models Greenlight Biosciences Inc. at approximately $3.9B (range $477M–$8.6B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 17 months.
Last raise 6.0 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.6× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 98% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 100% of those peers.
Peoplefiled
22 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.